The Upgraded Games: Tech’s High-Stakes Gamble Falls Short with $60 Million in Losses
In May, I visited Las Vegas to witness the Enhanced Games, an unconventional sporting event that permits athletes to use performance-enhancing substances often banned in traditional competitions. Dubbed the “steroid Olympics,” this event was organized by a telehealth firm with notable backers, including Peter Thiel, and staff members from sectors like cryptocurrency, artificial intelligence, and biotechnology.
However, the event failed to live up to its high expectations. Initially lauded by its organizers as a revolutionary occurrence in sports, the Enhanced Games produced few remarkable performances, with just one world record being set in swimming—a discipline known for frequent record-breaking feats.
Beyond the lackluster competition, the event also marked a significant financial setback for its organizers. Recently, the Enhanced Group reported a staggering net loss of nearly $62 million for the second quarter, predominantly attributed to the costs associated with hosting the games.
Established in 2023, Enhanced Group went public this year at a valuation of $1.2 billion. The company offers personalized health treatments through a digital telehealth platform, selling FDA-approved items such as peptides, testosterone shots, and GLP-1 medications for weight loss.
In its quarterly earnings report, Enhanced Group indicated revenue of $17.7 million for the last quarter, with most of the revenue stemming from sponsorships linked to the Enhanced Games rather than its core telehealth operations. This raises questions about the performance of its primary business and casts doubt on earlier assurances from company leaders that the games would continue annually, as sustaining such losses year after year seems untenable without significant income growth.
The company might be hinting at a strategic shift. In its earnings report, it introduced a new online series called Enhanced Breakers, which operates at a much lower cost compared to the full Games but aims to keep athletes active, audiences entertained, sponsors engaged, and performance medicine visible throughout the year.
Despite Enhanced Group’s struggles, the surrounding industry is thriving. The peptide market is experiencing rapid growth, bolstered by a recent decision from the FDA during the Trump administration to reclassify several substances that had previously existed in a vague legal zone. While this change doesn’t immediately allow for widespread sale of these products—since further review is necessary—it does indicate governmental interest in deregulating the sector.
The FDA operates under the U.S. Department of Health and Human Services, which is overseen by Robert F. Kennedy Jr., known for his controversial health opinions. His views have drawn sharp criticism from health experts within and outside the government, who label them as hazardous, yet this has not hindered the industry’s growth.
Silicon Valley remains a key player in the peptide startup scene, with enterprises such as Superpower and Noho Labs tapping into the tech sector’s enthusiasm for biohacking and trendy health products. The rapid expansion of this sector often outpaces the legal frameworks intended to regulate it, leaving state governments struggling to keep up with the evolving landscape.
